The healthcare expenditure on retailers of medical goods in France experienced various fluctuations from 2013 to 2023. Starting with minor declines, the value saw notable increases particularly in 2018 and 2019 with year-on-year growth of 1.88% and 1.55%, respectively. A significant rise occurred in 2021 with an 11.18% increase, likely influenced by the COVID-19 pandemic. However, this spike was followed by an 8.15% decline in 2022 as market adjustments took place. By 2023, the expenditure stabilized with a modest 0.5% increase, positioning the value at 45.94 billion Euros.
Looking ahead, the forecasted data from 2024 to 2028 indicates a steady upward trend with an average annual growth rate (CAGR) of 0.38%. Year-on-year increases are projected to range from 0.48% to 0.98%, suggesting more stability in the market conditions.
Future trends to watch for include:
- Potential economic impacts from global health crises or changes in public health policies
- Technological advancements influencing the types and cost of medical goods
- Shifts in consumer behavior towards preventative care requiring different medical products
- Governmental healthcare budget changes affecting overall spending power
